MedTech Acquisition - Warrants (18/12/2025) Total Revenue

As of the most recent data (June 2026), MTACW shows a total revenue of $45M. That compares with $36M in the prior-year period — up 25.2% year over year. That is below the sector sector average of $1.3B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MTACW's total revenue is now $45M (was $36M) — a 25.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether MedTech Acquisition - Warrants (18/12/2025) is outperforming or lagging.

The its sector sector average total revenue is about $1.3B. MedTech Acquisition - Warrants (18/12/2025) is at $45M, which is lower that average. That is roughly 96.6% below the sector mean. Use the comparison chart on this page to see how MTACW stacks up against individual peers as well.

Tracking MTACW's total revenue over time shows whether MedTech Acquisition - Warrants (18/12/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $45M That compares with $36M in the prior-year period — up 25.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total revenue page, Stockcircle has MedTech Acquisition - Warrants (18/12/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $45M) with ownership activity and broader fundamentals.